Ghrelin binding nucleic acids

Details for Australian Patent Application No. 2012216540 (hide)

Owner Noxxon Pharma AG

Inventors Klussmann, Sven; Helmling, Steffen; Eulberg, Dirk; Maasch, Christian; Jarosch, Florian

Agent Pizzeys

Pub. Number AU-A-2012216540

Parent 2006233647

Filing date 30 August 2012

Wipo publication date 20 September 2012

International Classifications

A61K 31/713 - Double-stranded nucleic acids or oligonucleotides

C12N 15/115 Mutation or genetic engineering - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 Drugs for disorders of the metabolism

Event Publications

13 September 2012 Complete Application Filed

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216540

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216541-Rack for a compost bed

2012216539-Device and method for manipulating an audio signal having a transient event